Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / VPTDF - Ventripoint To Resume Trading at the Market Opening Friday September 25 2020


VPTDF - Ventripoint To Resume Trading at the Market Opening Friday September 25 2020

(TheNewswire)



Toronto,Ontario -TheNewswire - September 23, 2020 - Ventripoint DiagnosticsLtd. (" Ventripoint " or the " Company "), (TSXV:VPT) is pleased to announce that it has beenadvised by the TSXV Exchange that the Company's shares will resumetrading at the opening of the market on Friday, September 25,2020.

"We are all so excited thatVentripoint starts trading on Friday. It has been a long, thoroughprocess to re-structure the Company with major advances in ourproducts and processes," states Dr. George Adams, ExecutiveChairman of Ventripoint. "The Company is well positioned forgrowth."

"We want to thank the manyshareholders who have sent us encouragement during this period ofuncertainty and need to thank the Ventripoint team, who used theirtime to significantly improve our product offerings and exhaustivelyrespond in detail to the marketplace's need for better cardiacanalytics," continued Dr. Adams.

The urgency to better understand thedamaging effects of COVID-19 on the heart has significantly elevatedthe profile of our products amongst the cardiovascular community. Nowwe can deploy our full team to close the sales established with tierone prospects and continue to penetrate the ever-increasing need foraccurate, clear and economic imaging of all quadrants of theheart.

About VentripointDiagnostics Ltd.

Ventripoint has become an industry leader in theapplication of AI (Artificial Intelligence) to echocardiography.Ventripoint's VMS products are powered by its proprietary KBRtechnology, which is the result of a decade of development andprovides accurate volumetric cardiac measurements equivalent to MRI.This affordable, gold-standard alternative allows cardiologistsgreater confidence in the management of their patients. Providingbetter care to patients serves as a springboard and basic standard forall of Ventripoint's products that guide our future developments. Inaddition, VMS+ is versatile and can be used with all ultrasoundsystems from any vendor supported by regulatory market approvals inthe U.S., Europe and Canada.

For further information, please contact:

Mr . Peter Weichler, Director

Email :peter@weichler.ca

Or

Mr. Clay Chase

Email: cc@sdthc.com

Phone: 858-456-7300

Neither the TSX Venture Exchange norits Regulation Services Provider (as that term is defined in thepolicies of the TSX Venture Exchange) accepts responsibility for theadequacy or accuracy of this news release.

Forward Looking Statements

This news release containsforward-looking statements and forward-looking information within themeaning of applicable securities laws. The use of any of the words"expect", "anticipate", "continue","estimate", "objective", "ongoing","may", "will", "project","should", "believe", "plans","intends'' and similar expressions are intended to identifyforward-looking information or statements. The forward-lookingstatements and information are based on certain key expectations andassumptions made by the Company. Although the Company believes thatthe expectations and assumptions on which such forward-lookingstatements and information are based are reasonable, undue relianceshould not be placed on the forward-looking statements and informationbecause the Company can give no assurance that they will prove to becorrect.

Since forward-looking statements andinformation address future events and conditions, by their very naturethey involve inherent risks and uncertainties. Actual results coulddiffer materially from those currently anticipated due to a number offactors and risks. Factors which could materially affect suchforward-looking information are described in the risk factors in theCompany's most recent annual management's discussion and analysis thatis available on the Company's profile on SEDAR at www.sedar.com. Readers are cautioned that the foregoinglist of factors is not exhaustive. The forward-looking statementsincluded in this news release are expressly qualified by thiscautionary statement. The forward-looking statements and informationcontained in this news release are made as of the date hereof and theCompany undertakes no obligation to update publicly or revise anyforward-looking statements or information, whether as a result of newinformation, future events or otherwise, unless so required byapplicable securities laws.

Copyright (c) 2020 TheNewswire - All rights reserved.

Stock Information

Company Name: VentriPoint Diagnostics Ltd
Stock Symbol: VPTDF
Market: OTC
Website: ventripoint.com

Menu

VPTDF VPTDF Quote VPTDF Short VPTDF News VPTDF Articles VPTDF Message Board
Get VPTDF Alerts

News, Short Squeeze, Breakout and More Instantly...